Home > Pharmaceuticals and Healthcare > EMEA (Europe, Middle East and Africa) Oncolytic Virus Market Report 2017...

EMEA (Europe, Middle East and Africa) Oncolytic Virus Market Report 2017

No. of Pages: 117No. of Tables & Figures: 135Published : 15 Nov 2017

Request Sample
 

In this report, the EMEA Oncolytic Virus market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oncolytic Virus for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Oncolytic Virus market competition by top manufacturers/players, with Oncolytic Virus sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Merck Otsuka Pharmaceutical Co Pfizer Roche Cold Genesys Genelux Latima Neotropix Shanghai Sunway Biotech SillaJen Takara Bio Theravir On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into HSV-based Oncolytic Viruses Adenoviruses-based Oncolytic Viruses Vaccinia Virus-based Oncolytic Viruses Vesicular Stomatitis Virus-based Oncolytic Viruses Newcastle Disease Virus-based Oncolytic Viruses On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Pharmaceutical Health Care Commerical If you have any special requirements, please let us know and we will offer you the report as you want.

 

Table of Contents EMEA (Europe, Middle East and Africa) Oncolytic Virus Market Report 2017 1 Oncolytic Virus Overview 1.1 Product Overview and Scope of Oncolytic Virus 1.2 Classification of Oncolytic Virus 1.2.1 EMEA Oncolytic Virus Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 EMEA Oncolytic Virus Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 HSV-based Oncolytic Viruses 1.2.4 Adenoviruses-based Oncolytic Viruses 1.2.5 Vaccinia Virus-based Oncolytic Viruses 1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses 1.2.7 Newcastle Disease Virus-based Oncolytic Viruses 1.3 EMEA Oncolytic Virus Market by Application/End Users 1.3.1 EMEA Oncolytic Virus Sales (Volume) and Market Share Comparison by Application (2012-2022 1.3.2 Pharmaceutical 1.3.3 Health Care 1.3.4 Commerical 1.4 EMEA Oncolytic Virus Market by Region 1.4.1 EMEA Oncolytic Virus Market Size (Value) Comparison by Region (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 Middle East Status and Prospect (2012-2022) 1.4.4 Africa Status and Prospect (2012-2022) 1.5 EMEA Market Size (Value and Volume) of Oncolytic Virus (2012-2022) 1.5.1 EMEA Oncolytic Virus Sales and Growth Rate (2012-2022) 1.5.2 EMEA Oncolytic Virus Revenue and Growth Rate (2012-2022) 2 EMEA Oncolytic Virus Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Oncolytic Virus Market Competition by Players/Manufacturers 2.1.1 EMEA Oncolytic Virus Sales Volume and Market Share of Major Players (2012-2017) 2.1.2 EMEA Oncolytic Virus Revenue and Share by Players (2012-2017) 2.1.3 EMEA Oncolytic Virus Sale Price by Players (2012-2017) 2.2 EMEA Oncolytic Virus (Volume and Value) by Type/Product Category 2.2.1 EMEA Oncolytic Virus Sales and Market Share by Type (2012-2017) 2.2.2 EMEA Oncolytic Virus Revenue and Market Share by Type (2012-2017) 2.2.3 EMEA Oncolytic Virus Sale Price by Type (2012-2017) 2.3 EMEA Oncolytic Virus (Volume) by Application 2.4 EMEA Oncolytic Virus (Volume and Value) by Region 2.4.1 EMEA Oncolytic Virus Sales and Market Share by Region (2012-2017) 2.4.2 EMEA Oncolytic Virus Revenue and Market Share by Region (2012-2017) 2.4.3 EMEA Oncolytic Virus Sales Price by Region (2012-2017) 3 Europe Oncolytic Virus (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Oncolytic Virus Sales and Value (2012-2017) 3.1.1 Europe Oncolytic Virus Sales Volume and Growth Rate (2012-2017) 3.1.2 Europe Oncolytic Virus Revenue and Growth Rate (2012-2017) 3.2 Europe Oncolytic Virus Sales and Market Share by Type 3.3 Europe Oncolytic Virus Sales and Market Share by Application 3.4 Europe Oncolytic Virus Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Oncolytic Virus Sales Volume by Countries (2012-2017) 3.4.2 Europe Oncolytic Virus Revenue by Countries (2012-2017) 3.4.3 Germany Oncolytic Virus Sales and Growth Rate (2012-2017) 3.4.4 France Oncolytic Virus Sales and Growth Rate (2012-2017) 3.4.5 UK Oncolytic Virus Sales and Growth Rate (2012-2017) 3.4.6 Russia Oncolytic Virus Sales and Growth Rate (2012-2017) 3.4.7 Italy Oncolytic Virus Sales and Growth Rate (2012-2017) 3.4.8 Benelux Oncolytic Virus Sales and Growth Rate (2012-2017) 4 Middle East Oncolytic Virus (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Oncolytic Virus Sales and Value (2012-2017) 4.1.1 Middle East Oncolytic Virus Sales Volume and Growth Rate (2012-2017) 4.1.2 Middle East Oncolytic Virus Revenue and Growth Rate (2012-2017) 4.2 Middle East Oncolytic Virus Sales and Market Share by Type 4.3 Middle East Oncolytic Virus Sales and Market Share by Application 4.4 Middle East Oncolytic Virus Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Oncolytic Virus Sales Volume by Countries (2012-2017) 4.4.2 Middle East Oncolytic Virus Revenue by Countries (2012-2017) 4.4.3 Saudi Arabia Oncolytic Virus Sales and Growth Rate (2012-2017) 4.4.4 Israel Oncolytic Virus Sales and Growth Rate (2012-2017) 4.4.5 UAE Oncolytic Virus Sales and Growth Rate (2012-2017) 4.4.6 Iran Oncolytic Virus Sales and Growth Rate (2012-2017) 5 Africa Oncolytic Virus (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Oncolytic Virus Sales and Value (2012-2017) 5.1.1 Africa Oncolytic Virus Sales Volume and Growth Rate (2012-2017) 5.1.2 Africa Oncolytic Virus Revenue and Growth Rate (2012-2017) 5.2 Africa Oncolytic Virus Sales and Market Share by Type 5.3 Africa Oncolytic Virus Sales and Market Share by Application 5.4 Africa Oncolytic Virus Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Oncolytic Virus Sales Volume by Countries (2012-2017) 5.4.2 Africa Oncolytic Virus Revenue by Countries (2012-2017) 5.4.3 South Africa Oncolytic Virus Sales and Growth Rate (2012-2017) 5.4.4 Nigeria Oncolytic Virus Sales and Growth Rate (2012-2017) 5.4.5 Egypt Oncolytic Virus Sales and Growth Rate (2012-2017) 5.4.6 Algeria Oncolytic Virus Sales and Growth Rate (2012-2017) 6 EMEA Oncolytic Virus Manufacturers/Players Profiles and Sales Data 6.1 Merck 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Oncolytic Virus Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Merck Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Otsuka Pharmaceutical Co 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Oncolytic Virus Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Pfizer 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Oncolytic Virus Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Pfizer Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Roche 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Oncolytic Virus Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Roche Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Cold Genesys 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Oncolytic Virus Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Cold Genesys Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Genelux 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Oncolytic Virus Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Genelux Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Latima 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Oncolytic Virus Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Latima Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Neotropix 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Oncolytic Virus Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Neotropix Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Shanghai Sunway Biotech 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Oncolytic Virus Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 SillaJen 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Oncolytic Virus Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 SillaJen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 Takara Bio 6.12 Theravir 7 Oncolytic Virus Manufacturing Cost Analysis 7.1 Oncolytic Virus Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Oncolytic Virus 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Oncolytic Virus Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Oncolytic Virus Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Oncolytic Virus Market Forecast (2017-2022) 11.1 EMEA Oncolytic Virus Sales, Revenue and Price Forecast (2017-2022) 11.1.1 EMEA Oncolytic Virus Sales and Growth Rate Forecast (2017-2022) 11.1.2 EMEA Oncolytic Virus Revenue and Growth Rate Forecast (2017-2022) 11.1.3 EMEA Oncolytic Virus Price and Trend Forecast (2017-2022) 11.2 EMEA Oncolytic Virus Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.3 Europe Oncolytic Virus Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.4 Middle Eastt Oncolytic Virus Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.5 Africa Oncolytic Virus Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.6 EMEA Oncolytic Virus Sales Forecast by Type (2017-2022) 11.7 EMEA Oncolytic Virus Sales Forecast by Application (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Oncolytic Virus Figure EMEA Oncolytic Virus Sales Volume (K Units) by Type (2012-2022) Figure EMEA Oncolytic Virus Sales Volume Market Share by Type (Product Category) in 2016 Figure HSV-based Oncolytic Viruses Product Picture Figure Adenoviruses-based Oncolytic Viruses Product Picture Figure Vaccinia Virus-based Oncolytic Viruses Product Picture Figure Vesicular Stomatitis Virus-based Oncolytic Viruses Product Picture Figure Newcastle Disease Virus-based Oncolytic Viruses Product Picture Figure EMEA Oncolytic Virus Sales Volume (K Units) by Application (2012-2022) Figure EMEA Sales Market Share of Oncolytic Virus by Application in 2016 Figure Pharmaceutical Examples Table Key Downstream Customer in Pharmaceutical Figure Health Care Examples Table Key Downstream Customer in Health Care Figure Commerical Examples Table Key Downstream Customer in Commerical Figure EMEA Oncolytic Virus Market Size (Million USD) by Region (2012-2022) Figure Europe Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2022) Figure Europe Oncolytic Virus Revenue (Million USD) Status and Forecast by Countries Figure Middle East Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2022) Figure Middle East Oncolytic Virus Revenue (Million USD) Status and Forecast by Countries Figure Africa Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2022) Figure Africa Oncolytic Virus Revenue (Million USD) Status and Forecast by Countries Figure EMEA Oncolytic Virus Sales Volume and Growth Rate (2012-2022) Figure EMEA Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2022) Figure EMEA Oncolytic Virus Market Major Players Product Sales Volume (K Units) (2012-2017) Table EMEA Oncolytic Virus Sales Volume (K Units) of Major Players (2012-2017) Table EMEA Oncolytic Virus Sales Share by Players (2012-2017) Figure 2016 Oncolytic Virus Sales Share by Players Figure 2017 Oncolytic Virus Sales Share by Players Figure EMEA Oncolytic Virus Market Major Players Product Revenue (Million USD) (2012-2017) Table EMEA Oncolytic Virus Revenue (Million USD) by Players (2012-2017) Table EMEA Oncolytic Virus Revenue Share by Players (2012-2017) Table 2016 EMEA Oncolytic Virus Revenue Share by Players Table 2017 EMEA Oncolytic Virus Revenue Share by Players Table EMEA Oncolytic Virus Sale Price (USD/Unit) by Players (2012-2017) Table EMEA Oncolytic Virus Sales (K Units) and Market Share by Type (2012-2017) Table EMEA Oncolytic Virus Sales Share by Type (2012-2017) Figure Sales Market Share of Oncolytic Virus by Type (2012-2017) Figure EMEA Oncolytic Virus Sales Market Share by Type (2012-2017) Table EMEA Oncolytic Virus Revenue (Million USD) and Market Share by Type (2012-2017) Table EMEA Oncolytic Virus Revenue Share by Type (2012-2017) Figure Revenue Market Share of Oncolytic Virus by Type in 2016 Table EMEA Oncolytic Virus Sale Price (USD/Unit) by Type (2012-2017) Table EMEA Oncolytic Virus Sales (K Units) and Market Share by Application (2012-2017) Table EMEA Oncolytic Virus Sales Share by Application (2012-2017) Figure Sales Market Share of Oncolytic Virus by Application (2012-2017) Figure EMEA Oncolytic Virus Sales Market Share by Application in 2016 Table EMEA Oncolytic Virus Sales (K Units) and Market Share by Region (2012-2017) Table EMEA Oncolytic Virus Sales Share by Region (2012-2017) Figure Sales Market Share of Oncolytic Virus by Region (2012-2017) Figure EMEA Oncolytic Virus Sales Market Share in 2016 Table EMEA Oncolytic Virus Revenue (Million USD) and Market Share by Region (2012-2017) Table EMEA Oncolytic Virus Revenue Share by Region (2012-2017) Figure Revenue Market Share of Oncolytic Virus by Region (2012-2017) Figure EMEA Oncolytic Virus Revenue Market Share Regions in 2016 Table EMEA Oncolytic Virus Sales Price (USD/Unit) by Region (2012-2017) Figure Europe Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Europe Oncolytic Virus Revenue and Growth Rate (2012-2017) Table Europe Oncolytic Virus Sales (K Units) by Type (2012-2017) Table Europe Oncolytic Virus Market Share by Type (2012-2017) Figure Europe Oncolytic Virus Market Share by Type in 2016 Table Europe Oncolytic Virus Sales (K Units) by Application (2012-2017) Table Europe Oncolytic Virus Market Share by Application (2012-2017) Figure Europe Oncolytic Virus Market Share by Application in 2016 Table Europe Oncolytic Virus Sales (K Units) by Countries (2012-2017) Table Europe Oncolytic Virus Sales Market Share by Countries (2012-2017) Figure Europe Oncolytic Virus Sales Market Share by Countries (2012-2017) Figure Europe Oncolytic Virus Sales Market Share by Countries in 2016 Table Europe Oncolytic Virus Revenue (Million USD) by Countries (2012-2017) Table Europe Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Europe Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Europe Oncolytic Virus Revenue Market Share by Countries in 2016 Figure Germany Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure France Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure UK Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Russia Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Italy Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Middle East Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Middle East Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2017) Table Middle East Oncolytic Virus Sales (K Units) by Type (2012-2017) Table Middle East Oncolytic Virus Market Share by Type (2012-2017) Figure Middle East Oncolytic Virus Market Share by Type (2012-2017) Table Middle East Oncolytic Virus Sales (K Units) by Applications (2012-2017) Table Middle East Oncolytic Virus Market Share by Applications (2012-2017) Figure Middle East Oncolytic Virus Sales Market Share by Application in 2016 Table Middle East Oncolytic Virus Sales Volume (K Units) by Countries (2012-2017) Table Middle East Oncolytic Virus Sales Volume Market Share by Countries (2012-2017) Figure Middle East Oncolytic Virus Sales Volume Market Share by Countries in 2016 Table Middle East Oncolytic Virus Revenue (Million USD) by Countries (2012-2017) Table Middle East Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Middle East Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Middle East Oncolytic Virus Revenue Market Share by Countries in 2016 Figure Saudi Arabia Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Israel Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure UAE Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Iran Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Africa Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Africa Oncolytic Virus Revenue (Million USD) and Growth Rate (2012-2017) Table Africa Oncolytic Virus Sales (K Units) by Type (2012-2017) Table Africa Oncolytic Virus Sales Market Share by Type (2012-2017) Figure Africa Oncolytic Virus Sales Market Share by Type (2012-2017) Figure Africa Oncolytic Virus Sales Market Share by Type in 2016 Table Africa Oncolytic Virus Sales (K Units) by Application (2012-2017) Table Africa Oncolytic Virus Sales Market Share by Application (2012-2017) Figure Africa Oncolytic Virus Sales Market Share by Application (2012-2017) Table Africa Oncolytic Virus Sales Volume (K Units) by Countries (2012-2017) Table Africa Oncolytic Virus Sales Market Share by Countries (2012-2017) Figure Africa Oncolytic Virus Sales Market Share by Countries (2012-2017) Figure Africa Oncolytic Virus Sales Market Share by Countries in 2016 Table Africa Oncolytic Virus Revenue (Million USD) by Countries (2012-2017) Table Africa Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Africa Oncolytic Virus Revenue Market Share by Countries (2012-2017) Figure Africa Oncolytic Virus Revenue Market Share by Countries in 2016 Figure South Africa Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Nigeria Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Egypt Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Algeria Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Table Merck Oncolytic Virus Basic Information List Table Merck Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Merck Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Merck Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Merck Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Otsuka Pharmaceutical Co Oncolytic Virus Basic Information List Table Otsuka Pharmaceutical Co Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Otsuka Pharmaceutical Co Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Otsuka Pharmaceutical Co Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Otsuka Pharmaceutical Co Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Pfizer Oncolytic Virus Basic Information List Table Pfizer Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Pfizer Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Pfizer Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Pfizer Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Roche Oncolytic Virus Basic Information List Table Roche Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Roche Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Roche Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Roche Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Cold Genesys Oncolytic Virus Basic Information List Table Cold Genesys Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Cold Genesys Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Cold Genesys Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Cold Genesys Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Genelux Oncolytic Virus Basic Information List Table Genelux Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Genelux Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Genelux Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Genelux Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Latima Oncolytic Virus Basic Information List Table Latima Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Latima Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Latima Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Latima Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Neotropix Oncolytic Virus Basic Information List Table Neotropix Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Neotropix Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Neotropix Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Neotropix Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Shanghai Sunway Biotech Oncolytic Virus Basic Information List Table Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Shanghai Sunway Biotech Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure Shanghai Sunway Biotech Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure Shanghai Sunway Biotech Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table SillaJen Oncolytic Virus Basic Information List Table SillaJen Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure SillaJen Oncolytic Virus Sales (K Units) and Growth Rate (2012-2017) Figure SillaJen Oncolytic Virus Sales Market Share in EMEA (2012-2017) Figure SillaJen Oncolytic Virus Revenue Market Share in EMEA (2012-2017) Table Takara Bio Oncolytic Virus Basic Information List Table Theravir Oncolytic Virus Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Oncolytic Virus Figure Manufacturing Process Analysis of Oncolytic Virus Figure Oncolytic Virus Industrial Chain Analysis Table Raw Materials Sources of Oncolytic Virus Major Manufacturers in 2016 Table Major Buyers of Oncolytic Virus Table Distributors/Traders List Figure EMEA Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2017-2022) Figure EMEA Oncolytic Virus Revenue and Growth Rate Forecast (2017-2022) Figure EMEA Oncolytic Virus Price (USD/Unit) and Trend Forecast (2017-2022) Table EMEA Oncolytic Virus Sales (K Units) Forecast by Region (2017-2022) Figure EMEA Oncolytic Virus Sales Market Share Forecast by Region (2017-2022) Table EMEA Oncolytic Virus Revenue (Million USD) Forecast by Region (2017-2022) Figure EMEA Oncolytic Virus Revenue Market Share Forecast by Region (2017-2022) Table Europe Oncolytic Virus Sales (K Units) Forecast by Countries (2017-2022) Figure Europe Oncolytic Virus Sales Market Share Forecast by Countries (2017-2022) Table Europe Oncolytic Virus Revenue (Million USD) Forecast by Countries (2017-2022) Figure Europe Oncolytic Virus Revenue Market Share Forecast by Countries (2017-2022) Table Middle East Oncolytic Virus Sales (K Units) Forecast by Countries (2017-2022) Figure Middle East Oncolytic Virus Sales Market Share Forecast by Countries (2017-2022) Table Middle East Oncolytic Virus Revenue (Million USD) Forecast by Countries (2017-2022) Figure Middle East Oncolytic Virus Revenue Market Share Forecast by Countries (2017-2022) Table Africa Oncolytic Virus Sales (K Units) Forecast by Countries (2017-2022) Figure Africa Oncolytic Virus Sales Market Share Forecast by Countries (2017-2022) Table Africa Oncolytic Virus Revenue (Million USD) Forecast by Countries (2017-2022) Figure Africa Oncolytic Virus Revenue Market Share Forecast by Countries (2017-2022) Table EMEA Oncolytic Virus Sales (K Units) Forecast by Type (2017-2022) Figure EMEA Oncolytic Virus Sales Market Share Forecast by Type (2017-2022) Table EMEA Oncolytic Virus Sales (K Units) Forecast by Application (2017-2022) Figure EMEA Oncolytic Virus Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Report ID : MSF405061

Publisher Name : QY Research

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's